ProfileGDS5822 / ILMN_3131197
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 80% 86% 81% 81% 81% 83% 82% 83% 83% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114580
GSM1276600PDAC Late Ablation Control 2300.686
GSM1276601PDAC Late Ablation Control 3216.881
GSM1276602PDAC Late Ablation 1153.781
GSM1276603PDAC Late Ablation 2163.481
GSM1276604PDAC Late Ablation 3223.183
GSM1303940PDAC Late Ablation_anti-CTLA4 1173.682
GSM1303941PDAC Late Ablation_anti-CTLA4 2265.383
GSM1303942PDAC Late Ablation_anti-CTLA4 3247.483